Richard M. Haugen
Directeur/Membre du Conseil chez OcuCure Therapeutics, Inc.
Profil
Richard M.
Haugen is currently a Director at OcuCure Therapeutics, Inc., Regenesis Bioremediation Products, Inc., and Anivive Lifesciences, Inc. In the past, he was the President, Chief Executive Officer & Director at Amylin Pharmaceuticals, Inc. from 1996 to 1998, and the Chief Operating Officer at Allergan, Inc. He holds an MBA from the University of Southern California.
Postes actifs de Richard M. Haugen
| Sociétés | Poste | Début |
|---|---|---|
OcuCure Therapeutics, Inc.
 OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Directeur/Membre du Conseil | - |
Regenesis Bioremediation Products, Inc.
 Regenesis Bioremediation Products, Inc. Chemicals: SpecialtyProcess Industries Regenesis Bioremediation Products, Inc. develops and sells chemical oxidation reagents. Its pRoducts include PlumeStop, Oxygen Release Compund, 3-D Microemulsion, Hydrogen Release Compound, Chemical Reducing Solution, Bio-Dechlor Inoculum, PersulfOx, RegenOx, and PetroCleanze. The firm also offers remediation solutions that include in situ sorption and biodegradation, in situ chemical oxidation, enhanced aerobic biodegradation, enhanced anaerobic bioremediation, bioaugmentation, metal immobilization, excavation, and vapor intrusion mitigation. The company was founded by Gavin S. Herbert in 1994 and is headquartered in San Clemente, CA. | Directeur/Membre du Conseil | - |
Anivive Lifesciences, Inc.
 Anivive Lifesciences, Inc. Pharmaceuticals: MajorHealth Technology Anivive Lifesciences, Inc. operates a pet pharmaceutical company. It provides medical treatments and vaccines for pets. The company was founded by Dylan Balsz and is headquartered in Long Beach, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Richard M. Haugen
| Sociétés | Poste | Fin |
|---|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Directeur Général | 26/03/1998 |
| ALLERGAN, INC. | Directeur des opérations | - |
Formation de Richard M. Haugen
| University of Southern California | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | Health Technology |
Regenesis Bioremediation Products, Inc.
Regenesis Bioremediation Products, Inc. Chemicals: SpecialtyProcess Industries Regenesis Bioremediation Products, Inc. develops and sells chemical oxidation reagents. Its pRoducts include PlumeStop, Oxygen Release Compund, 3-D Microemulsion, Hydrogen Release Compound, Chemical Reducing Solution, Bio-Dechlor Inoculum, PersulfOx, RegenOx, and PetroCleanze. The firm also offers remediation solutions that include in situ sorption and biodegradation, in situ chemical oxidation, enhanced aerobic biodegradation, enhanced anaerobic bioremediation, bioaugmentation, metal immobilization, excavation, and vapor intrusion mitigation. The company was founded by Gavin S. Herbert in 1994 and is headquartered in San Clemente, CA. | Process Industries |
Anivive Lifesciences, Inc.
Anivive Lifesciences, Inc. Pharmaceuticals: MajorHealth Technology Anivive Lifesciences, Inc. operates a pet pharmaceutical company. It provides medical treatments and vaccines for pets. The company was founded by Dylan Balsz and is headquartered in Long Beach, CA. | Health Technology |
